Header image

Oral Presentations 33: Cardiovascular 5

Tracks
Track 1
Thursday, July 16, 2026
9:00 AM - 10:30 AM

Speaker

Agenda Item Image
Mr Liam Griffiths
University Of Queensland

Antibody-Dependent Cellular Cytotoxicity (ADCC) contributes to Trastuzumab-associated cardiotoxicity.

Abstract

Biography

Agenda Item Image
Prof Canan G. Nebigil
University Of Strasbourg, Inserm Umr 1260

The Prokineticin/PKR1 Signaling Axis in Anthracycline Cardiotoxicity: Mechanisms/Biomarker potential/ Novel Cardioprotective Strategy

Abstract

Biography

Agenda Item Image
Prof Georgios Kararigas
Unic Athens

The curcumin derivative C66 ameliorates doxorubicin-induced cardiotoxicity

Abstract

Biography

Dr Margaret Cunningham
Senior Lecturer In Pharmacology,
University of Strathclyde

Multi-level insights into connexin-43 alterations in doxorubicin cardiotoxicity

Abstract

Biography

Agenda Item Image
Dr Miles De Blasio
Senior Research Fellow, Group Leader
Monash University

HDAC inhibitor tasquinimod limits diabetes induced cardiomyopathy

Abstract

Biography

loading